Stock futures are slightly higher this morning as markets brace for the Federal Reserve’s rate-decision later this week. The core of sentiment seems driven by widespread expectations that the Fed will deliver a 25 basis-point cut, though there still remains unease under the surface. The challenge facing the Fed given uncertainty over what constitutes a “neutral” interest rate could make this week’s meeting contentious.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Meanwhile, a soft U.S. dollar is supporting gold, which in turn reinforces the broader risk-on tone across both equities and commodities.
In pre-market trading, S&P 500 futures rose 0.15%, Nasdaq futures rose 0.30% and Dow futures rose 0.04%.
Check out this morning’s top movers from around Wall Street, compiled by The Fly.
HIGHER –
- Kymera Therapeutics (KYMR) up 35% after reporting clinical results from the BroADen Phase 1b atopic dermatitis clinical trial of KT-621
- Confluent (CFLT) up 29% after entering into a definitive agreement under which IBM (IBM) will acquire all of the issued and outstanding common shares of the company for $31 per share
- Broadcom (AVGO) up 3% after The Information reported Microsoft (MSFT) is in talks to design custom chips with Broadcom, switching its business from Marvell (MRVL)
LOWER –
- Marvell (MRVL) down 7% after the report that Microsoft (MSFT) is in talks to design custom chips with Broadcom, switching its business from the company
- CoreWeave (CRWV) down 4% after $2B convertible debt offering
- Agios Pharmaceuticals (AGIO) down 2% after announcing that the FDA has not yet issued a regulatory decision on the supplemental new drug application for mitapivat for the treatment of adult patients with non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia and that the sNDA remains under active review
- Tesla (TSLA) down 1% after Morgan Stanley downgraded the stock to Equal Weight from Overweight with a price target of $425, up from $410, as a new analyst took over coverage
- ITT (ITT) down 1% after 7M share common stock offering
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CFLT: